J
Joy M. Schmitz
Researcher at University of Texas Health Science Center at Houston
Publications - 189
Citations - 8645
Joy M. Schmitz is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Cocaine dependence & Abstinence. The author has an hindex of 41, co-authored 174 publications receiving 7846 citations. Previous affiliations of Joy M. Schmitz include University of Texas Health Science Center at San Antonio & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Psychiatric aspects of impulsivity
TL;DR: Before treatment studies on impulsivity can move forward, measures of impulsivity that capture the core aspects of this behavior need to be refined and tested on the basis of an ideologically neutral model of impulsiveness.
Journal ArticleDOI
The impact of impulsivity on cocaine use and retention in treatment
F. Gerard Moeller,Donald M. Dougherty,Ernest S. Barratt,Joy M. Schmitz,Alan C. Swann,John Grabowski +5 more
TL;DR: It is shown that impulsivity is a significant predictor of cocaine use and treatment retention, and suggests the need for targeting impulsivity in cocaine dependence treatment.
Journal ArticleDOI
Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids
Gregory J. Dehmer,Jeffrey J. Popma,E K van den Berg,Eric J. Eichhorn,J. B. Prewitt,William B. Campbell,L Jennings,James T. Willerson,Joy M. Schmitz +8 more
TL;DR: It is suggested that a dietary supplement of n-3 fatty acids, administered for one week before and for six months after coronary angioplasty, is safe and reduces the occurrence of early restenosis after that procedure.
Journal ArticleDOI
Dextroamphetamine for cocaine-dependence treatment : A double-blind randomized clinical trial
John Grabowski,Howard M. Rhoades,Joy M. Schmitz,Angela L. Stotts,Lee Ann Daruzska,Dan Creson,F. Moeller +6 more
TL;DR: A properly implemented agonist treatment regimen should improve retention and reduce illicit drug use, and the results provide support for additional examination of the agonist model in psychostimulantdependence treatment.
Journal ArticleDOI
Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
John Grabowski,Howard M. Rhoades,Angela L. Stotts,Katherine Cowan,Charles Kopecky,Anne H. Dougherty,F. Gerard Moeller,Sohela Hassan,Joy M. Schmitz +8 more
TL;DR: The results provide support for the agonist- like (d-amphetamine) model in cocaine dependence treatment but not for antagonist-like (risperidone) treatment, and coincide with previous reports of amphetamine or ris peridone administered singly in cocaine-dependent individuals.